JBT MAREL CORP (JBTM) Stock Fundamental Analysis

NYSE:JBTM • US4778391049

163.36 USD
-2 (-1.21%)
At close: Feb 12, 2026
163.36 USD
0 (0%)
After Hours: 2/12/2026, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, JBTM scores 3 out of 10 in our fundamental rating. JBTM was compared to 131 industry peers in the Machinery industry. JBTM may be in some trouble as it scores bad on both profitability and health. JBTM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • JBTM had positive earnings in the past year.
  • JBTM had a positive operating cash flow in the past year.
  • JBTM had positive earnings in each of the past 5 years.
  • JBTM had a positive operating cash flow in each of the past 5 years.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.35%, JBTM is doing worse than 73.28% of the companies in the same industry.
  • With a Return On Equity value of -2.50%, JBTM is not doing good in the industry: 71.76% of the companies in the same industry are doing better.
  • JBTM has a Return On Invested Capital of 1.95%. This is in the lower half of the industry: JBTM underperforms 69.47% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for JBTM is below the industry average of 10.21%.
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROIC 1.95%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • In the last couple of years the Profit Margin of JBTM has declined.
  • The Operating Margin of JBTM (4.81%) is worse than 62.60% of its industry peers.
  • JBTM's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 35.80%, JBTM is doing good in the industry, outperforming 66.41% of the companies in the same industry.
  • JBTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.81%
PM (TTM) N/A
GM 35.8%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

  • JBTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • JBTM has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, JBTM has more shares outstanding
  • Compared to 1 year ago, JBTM has a worse debt to assets ratio.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • JBTM has an Altman-Z score of 2.05. This is not the best score and indicates that JBTM is in the grey zone with still only limited risk for bankruptcy at the moment.
  • JBTM's Altman-Z score of 2.05 is in line compared to the rest of the industry. JBTM outperforms 41.98% of its industry peers.
  • JBTM has a debt to FCF ratio of 6.97. This is a slightly negative value and a sign of low solvency as JBTM would need 6.97 years to pay back of all of its debts.
  • JBTM has a Debt to FCF ratio (6.97) which is comparable to the rest of the industry.
  • JBTM has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
  • JBTM has a Debt to Equity ratio of 0.43. This is comparable to the rest of the industry: JBTM outperforms 56.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Altman-Z 2.05
ROIC/WACC0.21
WACC9.17%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • JBTM has a Current Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • JBTM has a worse Current ratio (0.93) than 88.55% of its industry peers.
  • A Quick Ratio of 0.53 indicates that JBTM may have some problems paying its short term obligations.
  • JBTM's Quick ratio of 0.53 is on the low side compared to the rest of the industry. JBTM is outperformed by 89.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

  • JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.08%, which is quite impressive.
  • Measured over the past 5 years, JBTM shows a small growth in Earnings Per Share. The EPS has been growing by 0.52% on average per year.
  • Looking at the last year, JBTM shows a very strong growth in Revenue. The Revenue has grown by 92.43%.
  • Measured over the past years, JBTM shows a decrease in Revenue. The Revenue has been decreasing by -2.48% on average per year.
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.91% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 4.83% on average over the next years.
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

  • JBTM is valuated quite expensively with a Price/Earnings ratio of 26.78.
  • The rest of the industry has a similar Price/Earnings ratio as JBTM.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, JBTM is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 20.72, the valuation of JBTM can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, JBTM is valued a bit cheaper than 65.65% of the companies in the same industry.
  • JBTM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.69.
Industry RankSector Rank
PE 26.78
Fwd PE 20.72
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBTM indicates a slightly more expensive valuation: JBTM is more expensive than 68.70% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as JBTM.
Industry RankSector Rank
P/FCF 31.04
EV/EBITDA 26.38
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • JBTM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • JBTM's earnings are expected to grow with 23.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.06
PEG (5Y)51.72
EPS Next 2Y24.33%
EPS Next 3Y23.91%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.25%, JBTM is not a good candidate for dividend investing.
  • JBTM's Dividend Yield is comparable with the industry average which is at 1.14.
  • Compared to an average S&P500 Dividend Yield of 1.80, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of JBTM has a limited annual growth rate of 0.48%.
  • JBTM has been paying a dividend for over 5 years, so it has already some track record.
  • JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • JBTM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of JBTM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-17.36%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (2/12/2026, 8:04:00 PM)

After market: 163.36 0 (0%)

163.36

-2 (-1.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-03
Earnings (Next)02-23
Inst Owners99.18%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change-8.81%
Market Cap8.49B
Revenue(TTM)3.26B
Net Income(TTM)-110.60M
Analysts83.33
Price Target159.94 (-2.09%)
Short Float %4.83%
Short Ratio5.31
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-17.36%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.24%
Min EPS beat(2)14.08%
Max EPS beat(2)26.4%
EPS beat(4)3
Avg EPS beat(4)11.49%
Min EPS beat(4)-8.58%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.11%
EPS beat(12)9
Avg EPS beat(12)6.09%
EPS beat(16)11
Avg EPS beat(16)6.44%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.12%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.62%
Revenue beat(16)5
Avg Revenue beat(16)-3.94%
PT rev (1m)0%
PT rev (3m)8.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.67%
EPS NY rev (1m)0%
EPS NY rev (3m)6.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.75%
Valuation
Industry RankSector Rank
PE 26.78
Fwd PE 20.72
P/S 2.61
P/FCF 31.04
P/OCF 24.04
P/B 1.92
P/tB N/A
EV/EBITDA 26.38
EPS(TTM)6.1
EY3.73%
EPS(NY)7.88
Fwd EY4.83%
FCF(TTM)5.26
FCFY3.22%
OCF(TTM)6.8
OCFY4.16%
SpS62.69
BVpS85.06
TBVpS-22.35
PEG (NY)1.06
PEG (5Y)51.72
Graham Number108.05
Profitability
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROCE 2.39%
ROIC 1.95%
ROICexc 1.98%
ROICexgc 10.75%
OM 4.81%
PM (TTM) N/A
GM 35.8%
FCFM 8.4%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexgc growth 3Y-1.29%
ROICexgc growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Debt/EBITDA 5.04
Cap/Depr 36%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 93.41%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 2.05
F-Score3
WACC9.17%
ROIC/WACC0.21
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%
EBIT growth 1Y-4.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year200.73%
EBIT Next 3Y57.42%
EBIT Next 5YN/A
FCF growth 1Y328.68%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y167.78%
OCF growth 3Y1.15%
OCF growth 5Y16.21%

JBT MAREL CORP / JBTM FAQ

Can you provide the ChartMill fundamental rating for JBT MAREL CORP?

ChartMill assigns a fundamental rating of 3 / 10 to JBTM.


What is the valuation status of JBT MAREL CORP (JBTM) stock?

ChartMill assigns a valuation rating of 3 / 10 to JBT MAREL CORP (JBTM). This can be considered as Overvalued.


How profitable is JBT MAREL CORP (JBTM) stock?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the financial health of JBT MAREL CORP (JBTM) stock?

The financial health rating of JBT MAREL CORP (JBTM) is 2 / 10.


How sustainable is the dividend of JBT MAREL CORP (JBTM) stock?

The dividend rating of JBT MAREL CORP (JBTM) is 3 / 10 and the dividend payout ratio is -17.36%.